IFNA1 and systemic lupus erythematosus: On the other hand, IFN signaling is pathogenic in SLE, driving disease activity through the activation of plasmacytoid dendritic cells, TLR (toll-like receptor) engagement, and feed-forward inflammatory loops [28,31].